Publications by authors named "Safana Siddique"
Article Synopsis
- From May 2022 to January 2023, around 30,000 monkeypox cases were reported in the U.S. and over 86,000 globally, prompting recommendations for the JYNNEOS vaccine for those at increased risk.
- The FDA authorized an Emergency Use Authorization (EUA) to allow the vaccine to be given intradermally, using about one-fifth of the subcutaneous dose while still generating an effective immune response.
- As of January 31, 2023, over 1.1 million doses of JYNNEOS were administered, achieving approximately 36.7% first dose and 22.7% full vaccination coverage among at-risk individuals, with continued vaccination efforts necessary to prevent potential